Literature DB >> 33900521

Hospitalization for venous thromboembolic disease management: a 10 years Registry in Buenos Aires, Argentina.

Fernando Javier Vázquez1, Maria Florencia Grande-Ratti2, Maria Elena Zapiola3, Diego Giunta3, Maria Lourdes Posadas-Martinez3.   

Abstract

Venous thromboembolism (VTE) is the most frequent cause of preventable mortality in hospitalized patients and the third leading cause of mortality due to vascular diseases. We aim to describe patients with VTE who required hospitalization, their clinical characteristics, management and evolution after discharge. Prospective cohort which included patients with acute and symptomatic VTE who required hospitalization in a single tertiary center for their management in a 10 years´ period (between 2006 and 2016). Patients were included at the time of VTE diagnosis; we collected baseline characteristics, risk stratification and initial therapeutic approach. They were periodically, prospectively and systematically followed up to evaluate recurrence, bleeding and/or death. Time-to-event analysis was performed for these outcomes related to evolucion after discharge. 3457 confirmed VTE episodes were included for the analysis (1985 DVT, 930 PE and 542 DVT + DVT), corresponding to 3157 patients. Most were elderly, the median age was 68 years (SD 16) with a predominance of women 57% (1955). Most frequent predisposing factors were immobility (45%), active cancer (35%), recent surgery (33%), obesity (26%), recent hospitalization (22%) and previous VTE (21%). One-fourth of pulmonary embolism had sPESI 0 points. Mortality, recurrence and bleeding rates within 30 days were 14%, 10% and 5% respectively. High proportion of VTE require hospitalization for their management, even PE with low sPESI. Mortality and complication remain elevated. We encourage the development and maintenance of more VTE registries in Latin America, to fully understand local characteristics of this disease.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Bleeding; Mortality; Recurrence; Registry; Venous thromboembolic disease

Mesh:

Year:  2021        PMID: 33900521     DOI: 10.1007/s11239-021-02459-7

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  8 in total

1.  Incidence, mortality and bleeding rates associated with pulmonary embolism in England between 1997 and 2015.

Authors:  Aleksander Kempny; Colm McCabe; Konstantinos Dimopoulos; Laura C Price; Michael Wilde; Rachel Limbrey; Michael A Gatzoulis; Stephen J Wort
Journal:  Int J Cardiol       Date:  2018-10-02       Impact factor: 4.164

2.  Incidence of hospital-acquired venous thromboembolic disease.

Authors:  María Florencia Grande Ratti; María Lourdes Posadas-Martínez; Jimena Vicens; Fernán González Bernaldo de Quirós; Fernando Javier Vázquez; Diego Hernán Giunta
Journal:  Rev Fac Cien Med Univ Nac Cordoba       Date:  2018-06-12

3.  Recurrent pulmonary embolism in patients treated because of acute venous thromboembolism: a prospective study.

Authors:  M Monreal; E Lafoz; J Ruiz; J M Callejas; A Arias
Journal:  Eur J Vasc Surg       Date:  1994-09

4.  The management and outcome of acute venous thromboembolism: a prospective registry including 4011 patients.

Authors:  Juan I Arcelus; Joseph A Caprini; Manuel Monreal; Carmen Suárez; José González-Fajardo
Journal:  J Vasc Surg       Date:  2003-11       Impact factor: 4.268

5.  A prospective study of the incidence of deep-vein thrombosis within a defined urban population.

Authors:  M Nordström; B Lindblad; D Bergqvist; T Kjellström
Journal:  J Intern Med       Date:  1992-08       Impact factor: 8.989

6.  Venous thromboembolism in patients with cancer: design and rationale of a multicentre, prospective registry (Cancer-VTE Registry).

Authors:  Yasuo Ohashi; Masataka Ikeda; Hideo Kunitoh; Mitsuru Sasako; Takuji Okusaka; Hirofumi Mukai; Keiichi Fujiwara; Mashio Nakamura; Tetsuya Kimura; Kei Ibusuki; Masato Sakon
Journal:  BMJ Open       Date:  2018-05-30       Impact factor: 2.692

7.  Incidence rate of symptomatic venous thromboembolic disease in patients from a medical care program in Buenos Aires, Argentina: a prospective cohort.

Authors:  Fernando Javier Vázquez; María Lourdes Posadas-Martínez; Jimena Vicens; Fernán González Bernaldo de Quirós; Diego Hernán Giunta
Journal:  Thromb J       Date:  2013-08-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.